414 related articles for article (PubMed ID: 32449901)
1. Roflumilast, a Phosphodiesterases-4 (PDE4) Inhibitor, Alleviates Sepsis‑induced Acute Kidney Injury.
Xu X; Liao L; Hu B; Jiang H; Tan M
Med Sci Monit; 2020 May; 26():e921319. PubMed ID: 32449901
[TBL] [Abstract][Full Text] [Related]
2. β-Casomorphin-7 Ameliorates Sepsis-Induced Acute Kidney Injury by Targeting NF-κB Pathway.
Zhang Z; Zhao H; Ge D; Wang S; Qi B
Med Sci Monit; 2019 Jan; 25():121-127. PubMed ID: 30610183
[TBL] [Abstract][Full Text] [Related]
3. CXCL8
Zhou Y; Xu W; Zhu H
Biol Res; 2019 May; 52(1):29. PubMed ID: 31084615
[TBL] [Abstract][Full Text] [Related]
4. Roflumilast improves resolution of sepsis-induced acute kidney injury by retarding late phase renal interstitial immune cells infiltration and leakage in urinary sediments.
Gupta K; Pandey S; Singh R; Kumari A; Sen P; Singh G
Fundam Clin Pharmacol; 2022 Feb; 36(1):114-132. PubMed ID: 34212425
[TBL] [Abstract][Full Text] [Related]
5. Roflumilast reverses polymicrobial sepsis-induced liver damage by inhibiting inflammation in mice.
Feng H; Chen J; Wang H; Cheng Y; Zou Z; Zhong Q; Xu J
Lab Invest; 2017 Sep; 97(9):1008-1019. PubMed ID: 28650427
[TBL] [Abstract][Full Text] [Related]
6. Flavonoid fisetin alleviates kidney inflammation and apoptosis via inhibiting Src-mediated NF-κB p65 and MAPK signaling pathways in septic AKI mice.
Ren Q; Guo F; Tao S; Huang R; Ma L; Fu P
Biomed Pharmacother; 2020 Feb; 122():109772. PubMed ID: 31918290
[TBL] [Abstract][Full Text] [Related]
7. Effect of Thymoquinone on Acute Kidney Injury Induced by Sepsis in BALB/c Mice.
Guo LP; Liu SX; Yang Q; Liu HY; Xu LL; Hao YH; Zhang XQ
Biomed Res Int; 2020; 2020():1594726. PubMed ID: 32626733
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting pannexin-1 alleviates sepsis-induced acute kidney injury via decreasing NLRP3 inflammasome activation and cell apoptosis.
Huang G; Bao J; Shao X; Zhou W; Wu B; Ni Z; Wang L
Life Sci; 2020 Aug; 254():117791. PubMed ID: 32416166
[TBL] [Abstract][Full Text] [Related]
9. Roflumilast prevents lymphotoxin α (TNF-β)-induced inflammation activation and degradation of type 2 collagen in chondrocytes.
Zhao J; Duan L; Wang R; Liu Y; Jiang J
Inflamm Res; 2020 Dec; 69(12):1191-1199. PubMed ID: 32990777
[TBL] [Abstract][Full Text] [Related]
10. PDE4 inhibition reduces neointima formation and inhibits VCAM-1 expression and histone methylation in an Epac-dependent manner.
Lehrke M; Kahles F; Makowska A; Tilstam PV; Diebold S; Marx J; Stöhr R; Hess K; Endorf EB; Bruemmer D; Marx N; Findeisen HM
J Mol Cell Cardiol; 2015 Apr; 81():23-33. PubMed ID: 25640159
[TBL] [Abstract][Full Text] [Related]
11. Effect of lncRNA CRNDE on sepsis-related kidney injury through the TLR3/NF-κB pathway.
Sun BQ; Sui YD; Huang H; Zou XB; Chen SC; Yu ZK
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10489-10497. PubMed ID: 31841203
[TBL] [Abstract][Full Text] [Related]
12. Tetrahydrocurcumin protects against sepsis-induced acute kidney injury via the SIRT1 pathway.
Li L; Liu X; Li S; Wang Q; Wang H; Xu M; An Y
Ren Fail; 2021 Dec; 43(1):1028-1040. PubMed ID: 34187277
[TBL] [Abstract][Full Text] [Related]
13. CID16020046, a GPR55 antagonist, attenuates sepsis‑induced acute kidney injury.
Chen R; Xu H; Guo Z; Zhang P; Chen J; Chen Z
Mol Med Rep; 2022 May; 25(5):. PubMed ID: 35244189
[TBL] [Abstract][Full Text] [Related]
14. Phosphodiestrase-1 and 4 inhibitors ameliorate liver fibrosis in rats: Modulation of cAMP/CREB/TLR4 inflammatory and fibrogenic pathways.
Essam RM; Ahmed LA; Abdelsalam RM; El-Khatib AS
Life Sci; 2019 Apr; 222():245-254. PubMed ID: 30858122
[TBL] [Abstract][Full Text] [Related]
15. The Phosphodiesterase-4 Inhibitor Roflumilast, a Potential Treatment for the Comorbidity of Memory Loss and Depression in Alzheimer's Disease: A Preclinical Study in APP/PS1 Transgenic Mice.
Wang H; Zhang FF; Xu Y; Fu HR; Wang XD; Wang L; Chen W; Xu XY; Gao YF; Zhang JG; Zhang HT
Int J Neuropsychopharmacol; 2020 Dec; 23(10):700-711. PubMed ID: 32645141
[TBL] [Abstract][Full Text] [Related]
16. The selective phosphodiesterase 4 inhibitor roflumilast and phosphodiesterase 3/4 inhibitor pumafentrine reduce clinical score and TNF expression in experimental colitis in mice.
Rieder F; Siegmund B; Bundschuh DS; Lehr HA; Endres S; Eigler A
PLoS One; 2013; 8(2):e56867. PubMed ID: 23468885
[TBL] [Abstract][Full Text] [Related]
17. Acute lung injury and acute kidney injury are established by four hours in experimental sepsis and are improved with pre, but not post, sepsis administration of TNF-α antibodies.
Bhargava R; Altmann CJ; Andres-Hernando A; Webb RG; Okamura K; Yang Y; Falk S; Schmidt EP; Faubel S
PLoS One; 2013; 8(11):e79037. PubMed ID: 24265742
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase-4 Inhibitor Roflumilast Attenuates Pulmonary Air Emboli-Induced Lung Injury.
Peng CK; Huang KL; Wu CP; Wu YK; Tzeng IS; Lan CC
J Surg Res; 2019 Sep; 241():24-30. PubMed ID: 31004869
[TBL] [Abstract][Full Text] [Related]
19. The phosphodiesterase type 4 inhibitor roflumilast suppresses inflammation to improve diabetic bladder dysfunction rats.
Ding H; Zhang P; Li N; Liu Y; Wang P
Int Urol Nephrol; 2019 Feb; 51(2):253-260. PubMed ID: 30474782
[TBL] [Abstract][Full Text] [Related]
20. [Early diagnostic value of neutrophil gelatinase-associated lipocalin and interleukin-18 in patients with sepsis-induced acute kidney injury].
Zhu L; Shi D
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Aug; 28(8):718-22. PubMed ID: 27434563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
